Allogeneic bone marrow transplantation for treatment of severe hemolytic anemia attributable to hexokinase deficiency.
Pediatric Marrow and Blood Cell Transplantation Program, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY; and.
Sajad
0000-0002-3731-608X
S
Khazal
Pediatric Marrow and Blood Cell Transplantation Program, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY; and.
Veronika
V
Polishchuk
Pediatric Marrow and Blood Cell Transplantation Program, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY; and.
Deepa
D
Manwani
Departments of Pediatrics, Pathology, and Genetics, Yale University, New Haven, CT.
Patrick G
PG
Gallagher
Pediatric Marrow and Blood Cell Transplantation Program, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY; and.
Samantha
S
Prinzing
Pediatric Marrow and Blood Cell Transplantation Program, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY; and.
Kris Michael
KM
Mahadeo
D000745:Anemia, Hemolytic, Congenital / Q000201:enzymology / Q000473:pathology / Q000628:therapy*; D001483:Base Sequence; D016026:Bone Marrow Transplantation / Q000379:methods*; D002675:Child, Preschool; D004252:DNA Mutational Analysis / Q000379:methods; D006593:Hexokinase / Q000172:deficiency / Q000235:genetics*; D006801:Humans; D008297:Male; D009154:Mutation; D012720:Severity of Illness Index; D014184:Transplantation, Homologous
C472074:HK1 protein, human; D006593:Hexokinase